L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
68,800
+3,300 (5.04%)
At close: Dec 5, 2025
320.02%
Market Cap 1.69T
Revenue (ttm) 79.99B
Net Income (ttm) 78.00B
Shares Out 24.62M
EPS (ttm) 3,050.54
PE Ratio 22.35
Forward PE n/a
Dividend 50.00 (0.08%)
Ex-Dividend Date Dec 29, 2025
Volume 1,276,838
Average Volume 606,610
Open 68,200
Previous Close 65,500
Day's Range 65,000 - 70,400
52-Week Range 16,130 - 70,400
Beta 1.08
RSI 70.58
Earnings Date Nov 14, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.